Literature DB >> 31248990

Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding.

Xiaoxiao Huang1, Richard D LeDuc2, Luca Fornelli2, Alissa J Schunter2, Richard L Bennett3, Neil L Kelleher2, Jonathan D Licht4.   

Abstract

NSD2 is a histone methyltransferase that specifically dimethylates histone H3 lysine 36 (H3K36me2), a modification associated with gene activation. Dramatic overexpression of NSD2 in t(4;14) multiple myeloma (MM) and an activating mutation of NSD2 discovered in acute lymphoblastic leukemia are significantly associated with altered gene activation, transcription, and DNA damage repair. The partner proteins through which NSD2 may influence critical cellular processes remain poorly defined. In this study, we utilized proximity-based labeling (BioID) combined with label-free quantitative MS to identify high confidence NSD2 interacting partners in MM cells. The top 24 proteins identified were involved in maintaining chromatin structure, transcriptional regulation, RNA pre-spliceosome assembly, and DNA damage. Among these, an important DNA damage regulator, poly(ADP-ribose) polymerase 1 (PARP1), was discovered. PARP1 and NSD2 have been found to be recruited to DNA double strand breaks upon damage and H3K36me2 marks are enriched at damage sites. We demonstrate that PARP1 regulates NSD2 via PARylation upon oxidative stress. In vitro assays suggest the PARylation significantly reduces NSD2 histone methyltransferase activity. Furthermore, PARylation of NSD2 inhibits its ability to bind to nucleosomes and further get recruited at NSD2-regulated genes, suggesting PARP1 regulates NSD2 localization and H3K36me2 balance. This work provides clear evidence of cross-talk between PARylation and histone methylation and offers new directions to characterize NSD2 function in DNA damage response, transcriptional regulation, and other pathways.
© 2019 Huang et al.

Entities:  

Keywords:  DNA damage; NSD2; PARP1; PARylation; epigenetics; histone methylation; protein complex; proteomics

Mesh:

Substances:

Year:  2019        PMID: 31248990      PMCID: PMC6699848          DOI: 10.1074/jbc.RA118.006159

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor.

Authors:  A Prokhortchouk; B Hendrich; H Jørgensen; A Ruzov; M Wilm; G Georgiev; A Bird; E Prokhortchouk
Journal:  Genes Dev       Date:  2001-07-01       Impact factor: 11.361

2.  Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining.

Authors:  Sheema Fnu; Elizabeth A Williamson; Leyma P De Haro; Mark Brenneman; Justin Wray; Montaser Shaheen; Krishnan Radhakrishnan; Suk-Hee Lee; Jac A Nickoloff; Robert Hromas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

3.  The macro domain is an ADP-ribose binding module.

Authors:  Georgios I Karras; Georg Kustatscher; Heeran R Buhecha; Mark D Allen; Céline Pugieux; Fiona Sait; Mark Bycroft; Andreas G Ladurner
Journal:  EMBO J       Date:  2005-05-19       Impact factor: 11.598

4.  The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.

Authors:  Eva Martinez-Garcia; Relja Popovic; Dong-Joon Min; Steve M M Sweet; Paul M Thomas; Leonid Zamdborg; Aaron Heffner; Christine Will; Laurence Lamy; Louis M Staudt; David L Levens; Neil L Kelleher; Jonathan D Licht
Journal:  Blood       Date:  2010-10-25       Impact factor: 22.113

5.  Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients.

Authors:  Jonathan J Keats; Christopher A Maxwell; Brian J Taylor; Michael J Hendzel; Marta Chesi; P Leif Bergsagel; Loree M Larratt; Michael J Mant; Tony Reiman; Andrew R Belch; Linda M Pilarski
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

6.  Characterization of novel SF3b and 17S U2 snRNP proteins, including a human Prp5p homologue and an SF3b DEAD-box protein.

Authors:  Cindy L Will; Henning Urlaub; Tilmann Achsel; Marc Gentzel; Matthias Wilm; Reinhard Lührmann
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

7.  The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.

Authors:  Josh Lauring; Abde M Abukhdeir; Hiroyuki Konishi; Joseph P Garay; John P Gustin; Qiuju Wang; Robert J Arceci; William Matsui; Ben Ho Park
Journal:  Blood       Date:  2007-10-17       Impact factor: 22.113

8.  Two highly related p66 proteins comprise a new family of potent transcriptional repressors interacting with MBD2 and MBD3.

Authors:  Marc Brackertz; Joern Boeke; Ru Zhang; Rainer Renkawitz
Journal:  J Biol Chem       Date:  2002-08-14       Impact factor: 5.157

9.  PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway.

Authors:  Raga Krishnakumar; W Lee Kraus
Journal:  Mol Cell       Date:  2010-09-10       Impact factor: 19.328

10.  p66alpha and p66beta of the Mi-2/NuRD complex mediate MBD2 and histone interaction.

Authors:  Marc Brackertz; Zihua Gong; Jörg Leers; Rainer Renkawitz
Journal:  Nucleic Acids Res       Date:  2006-01-13       Impact factor: 16.971

View more
  5 in total

Review 1.  Proximity Labeling Techniques to Study Chromatin.

Authors:  Henning Ummethum; Stephan Hamperl
Journal:  Front Genet       Date:  2020-05-12       Impact factor: 4.599

2.  Alternatively Splicing Interactomes Identify Novel Isoform-Specific Partners for NSD2.

Authors:  Weidi Wang; Yucan Chen; Jingjing Zhao; Liang Chen; Weichen Song; Li Li; Guan Ning Lin
Journal:  Front Cell Dev Biol       Date:  2021-02-25

Review 3.  DNA Damage Response in Multiple Myeloma: The Role of the Tumor Microenvironment.

Authors:  Takayuki Saitoh; Tsukasa Oda
Journal:  Cancers (Basel)       Date:  2021-01-28       Impact factor: 6.639

4.  PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib.

Authors:  Xia Ding; Zhou Zhu; John Lapek; Elizabeth A McMillan; Alexander Zhang; Chi-Yeh Chung; Sara Dubbury; Jennifer Lapira; Sarah Firdaus; Xiaolin Kang; Jingjin Gao; Jon Oyer; John Chionis; Robert A Rollins; Lianjie Li; Sherry Niessen; Shubha Bagrodia; Lianglin Zhang; Todd VanArsdale
Journal:  Sci Rep       Date:  2022-07-21       Impact factor: 4.996

Review 5.  The Role of PARPs in Inflammation-and Metabolic-Related Diseases: Molecular Mechanisms and Beyond.

Authors:  Yueshuang Ke; Chenxin Wang; Jiaqi Zhang; Xiyue Zhong; Ruoxi Wang; Xianlu Zeng; Xueqing Ba
Journal:  Cells       Date:  2019-09-06       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.